PODCAST: Japanese Auto Cuts, and a Drugmaker’s Fall
By Doug Young & Rene Vanguestaine Nissan and Honda weigh major cuts of up to 30% in their China car production. What's driving the trend, and is it likely to…
I-Mab gets new CEO after long search. Sale of the company coming next?
The drug developer filled an 18-month-long vacuum in its top position by appointing an industry veteran with a history of deal-making as its new CEO Key Takeaways: I-Mab has appointed…
FAST NEWS: Kintor Pharma Strapped for Cash as Loss Widens
The latest: Kintor Pharmaceutical Ltd. (9939.HK) announced on Wednesday it did not record any revenue in the first half of the year, as its net loss widened to 518 million yuan ($75…
FAST NEWS: Simcere Pharma New Co-CEO Sends Investors Scurrying
The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) announced late Wednesday that executive director Tang Renhong has been appointed as Co-CEO and will assist Chairman and CEO Ren Jinsheng in leading…
I-Mab Shaken by Management Moves, Merger Talk and Delisting Threat
Cancer drug maker has been in a wide range of market-moving headlines lately, though its stock still trades near an all-time low Key Takeaways: I-Mab was placed on a list…
FAST NEWS: InnoCare Pharma Sees Losses Shrinking, But Stock Still Slumps
The latest: Drug maker InnoCare Pharma Ltd. (9969.HK) announced Wednesday evening that it expects to report a net loss of up to 100 million yuan ($15.7 million) for all 2021,…
FAST NEWS: Legend Biotech Halts Trials for LB1901 CAR-T Therapy Drug
The latest: Legend Biotech Corp. (LEGN.US) announced that the Phase 1 clinical trial for its LB1901 drug has been put on hold. LB1901 is the company’s autologous chimeric antigen receptor…